COMPANY PROFILE

Lattice Medical

Lattice Medical develops MATTISSE, a fully degradable 3D printed breast implant for natural, uncomplicated breast restoration

Loos, FranceFounded 2017Biotech & Life Sciences

Valuation $100–250M Last recorded · 2025

Revenue <$1M Latest reported FY

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Lattice Medical

Developer of a medical device designed to help manufacture and designing of soft tissue reconstruction devices for breast reconstruction. The company specializes in implants for breast reconstruction after cancer that help in personalized reconstruction with a single surgery, enabling health professionals to get access to a medical device that assists in reconstructing the lost volume of the patients after mastectomy. Keywords: Healthcare Devices, Services, Supplies, Autologous Fat Tissue, Soft Tissue Implant, Soft Tissue Repair, Soft Tissue Replacement, Soft Tissue Therapeutics, Soft Tissue Treatment.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Loos, France
Employees: 39
Open positions: None listed
Dealroom signal: 91.8/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, Oncology, medical implants, Surgery, Biomaterials
Technology: Hardware, 3D Technology, Deep Tech
Business model: Manufacturing
Client focus: b2b, b2c
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Oct 2025	$47M	$189M	Nord France Amorcage · CAPTECH Santé Nutrition · SPRIM · Bpifrance	↗
GRANTOther financing	Nov 2024	$200K	—	MedTech Innovator	↗

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Lattice Medical website traffic

Latest recorded traffic for Lattice Medical is 3K monthly website visits, down 43.4% over the last three months. Lattice Medical's team grew 0% over the past year.

Latest monthly visits3K 3-month web change-43.4% 1-year team growth0%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Technicien(ne) d’extrusion et impression 3DLoos, Hauts-de-France, France · Design · Aug 25, 2026 Ingénieur(e) Méthodes Dispositifs MédicauxLoos, Hauts-de-France, France · Accounting · Aug 9, 2026 CDD - 12 mois Ingénieur(e) Méthodes Dispositifs Médicaux Loos Découvrir la fiche de posteFrance, Western Europe, Europe · Other · Jul 30, 2026

3 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
FIFizimedConnected medical devices for at-home pelvic floor rehabilitation	Strasbourg, France	Operational	23	$6.7M	$18M
HEHealshapePersonalized, resorbable bioprosthesis for natural breast reconstruction	Nantes, France	Operational
DIDiabeloopMedical device company for diabetes and closed-loop system and also develops disruptive technological innovations to automate the treatment of diabetes	Grenoble, France	Operational
NONorakerDesigning, manufacturing, and marketing of biomaterial-based implants to preserve the quality of the bone	Lyon, France	Operational
ATAenitis TechnologiesDeveloping a cell treatment device	Paris, France	Operational
SISmart ImmuneDevelops off-the-shelf allogeneic T-cell progenitor therapies to restore a fully functional immune system in patients with cancer and severe infections	Paris, France	Operational
THTHERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care	Paris, France	Operational
GRGraphealGrapheal develops and manufactures true monolayer graphene on flexible substrates, enabling next-generation sustainable and cost-effective sensor platforms especially when coupled with IOTs	Grenoble, France	Operational